Skip to main content
Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.180
-0.100 (-4.39%)
Nov 20, 2024, 4:00 PM EST - Market closed

Sunshine Biopharma Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Sunshine Biopharma.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for SBFM.

Recommendation Trends

Rating Aug '23
Strong Buy 0
Buy 0
Hold 0
Sell 0
Strong Sell 0
Total 0

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
David Bouchey
Aegis Capital
 Aegis Capital
Strong Buy
Initiates
$5,200
 Strong Buy Initiates $5,200 +238,432.11% Aug 7, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
44.98M
from 24.09M
Increased by 86.70%
Revenue Next Year
102.00M
from 44.98M
Increased by 126.76%
EPS This Year
15.71
from -380.00
EPS Next Year
203.80
from 15.71
Increased by 1,197.40%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025
Revenue
21.12K71.41K228.43K4.35M24.09M44.98M102.00M
Revenue Growth
-238.10%219.88%1,802.41%454.42%86.70%126.76%
EPS
-----380.0015.71203.80
EPS Growth
------1,197.40%
Forward PE
-----0.140.01
No. Analysts -----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High 46.3M 105.0M
Avg 45.0M 102.0M
Low 43.2M 98.0M

Revenue Growth

Revenue Growth 20242025
High
92.2%
133.4%
Avg
86.7%
126.8%
Low
79.4%
117.9%

EPS Forecast

EPS 20242025
High 16.17 209.79
Avg 15.71 203.80
Low 15.09 195.80

EPS Growth

EPS Growth 20242025
High -
1,235.6%
Avg -
1,197.4%
Low -
1,146.5%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.